Human umbilical cord blood stem cells upregulate matrix metalloproteinase-2 in rats after spinal cord injury

Neurobiology of Disease

Volumn 36, Issue 1, 2009, Pages 200-212

  Veeravalli, Krishna Kumar ^a   Dasari, Venkata Ramesh ^a   Tsung, Andrew J ^a   Dinh, Dzung H ^a   Gujrati, Meena ^a   Fassett, Dan ^a   Rao, Jasti S ^a  

^a UNIVERSITY OF ILLINOIS   (United States)

Author keywords

Glial scar; Human umbilical cord blood mesenchymal stem cells; MMP 2; Spinal cord injury; Spinal neurons

Indexed keywords

CYCLOSPORIN A; GELATINASE A; PROTEOCHONDROITIN SULFATE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORD BLOOD STEM CELL TRANSPLANTATION; ENZYME ACTIVITY; GRAFT REJECTION; HUMAN; HUMAN CELL; IMMUNOSUPPRESSIVE TREATMENT; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; NERVE CELL CULTURE; NEUROPROTECTION; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SPINAL CORD INJURY; SPINAL CORD NERVE CELL; THERAPY EFFECT; UPREGULATION;

ANALYSIS OF VARIANCE; ANIMALS; ANIMALS, NEWBORN; CELL SURVIVAL; CELLS, CULTURED; CICATRIX; COCULTURE TECHNIQUES; CORD BLOOD STEM CELL TRANSPLANTATION; DISEASE MODELS, ANIMAL; FETAL BLOOD; HUMANS; L-LACTATE DEHYDROGENASE; MALE; MATRIX METALLOPROTEINASE 2; NEURONS; RATS; RATS, INBRED LEW; RATS, SPRAGUE-DAWLEY; SPINAL CORD; SPINAL CORD INJURIES; TIME FACTORS; TISSUE INHIBITOR OF METALLOPROTEINASES; UP-REGULATION;

EID: 69749088023     PISSN: 09699961     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nbd.2009.07.012     Document Type: Article

References (40)

1. Amar A.P., and Levy M.L. Pathogenesis and pharmacological strategies for mitigating secondary damage in acute spinal cord injury. Neurosurgery 44 (1999) 1027-1039
2. Anthony D.C., Miller K.M., Fearn S., Townsend M.J., Opdenakker G., Wells G.M., Clements J.M., Chandler S., Gearing A.J., and Perry V.H. Matrix metalloproteinase expression in an experimentally-induced DTH model of multiple sclerosis in the rat CNS. J. Neuroimmunol. 87 (1998) 62-72
3. Asahi M., Wang X., Mori T., Sumii T., Jung J.C., Moskowitz M.A., Fini M.E., and Lo E.H. Effects of matrix metalloproteinase-9 gene knock-out on the proteolysis of blood-brain barrier and white matter components after cerebral ischemia. J. Neurosci. 21 (2001) 7724-7732
4. Chandler S., Coates R., Gearing A., Lury J., Wells G., and Bone E. Matrix metalloproteinases degrade myelin basic protein. Neurosci. Lett. 201 (1995) 223-226
5. Chang C., and Werb Z. The many faces of metalloproteases: cell growth, invasion, angiogenesis and metastasis. Trends Cell Biol. 11 (2001) S37-S43
6. Crowe M.J., Bresnahan J.C., Shuman S.L., Masters J.N., and Beattie M.S. Apoptosis and delayed degeneration after spinal cord injury in rats and monkeys. Nat. Med. 3 (1997) 73-76
7. Dasari V.R., Spomar D.G., Gondi C.S., Sloffer C.A., Saving K.L., Gujrati M., Rao J.S., and Dinh D.H. Axonal remyelination by cord blood stem cells after spinal cord injury. J. Neurotrauma 24 (2007) 391-410
8. Dasari V.R., Spomar D.G., Li L., Gujrati M., Rao J.S., and Dinh D.H. umbilical cord blood stem cell mediated downregulation of fas improves functional recovery of rats after spinal cord injury. Neurochem. Res. 33 (2008) 134-149
9. Duchossoy Y., Horvat J.C., and Stettler O. MMP-related gelatinase activity is strongly induced in scar tissue of injured adult spinal cord and forms pathways for ingrowing neurites. Mol. Cell. Neurosci. 17 (2001) 945-956
10. Gasche Y., Copin J.C., Sugawara T., Fujimura M., and Chan P.H. Matrix metalloproteinase inhibition prevents oxidative stress-associated blood-brain barrier disruption after transient focal cerebral ischemia. J. Cereb. Blood Flow Metab. 21 (2001) 1393-1400
11. Gijbels K., Masure S., Carton H., and Opdenakker G. Gelatinase in the cerebrospinal fluid of patients with multiple sclerosis and other inflammatory neurological disorders. J. Neuroimmunol. 41 (1992) 29-34
12. Gijbels K., Proost P., Masure S., Carton H., Billiau A., and Opdenakker G. Gelatinase B is present in the cerebrospinal fluid during experimental autoimmune encephalomyelitis and cleaves myelin basic protein. J. Neurosci. Res. 36 (1993) 432-440
13. Goussev S., Hsu J.Y., Lin Y., Tjoa T., Maida N., Werb Z., and Noble-Haeusslein L.J. Differential temporal expression of matrix metalloproteinases after spinal cord injury: relationship to revascularization and wound healing. J. Neurosurg. 99 (2003) 188-197
14. Gruner J.A. A monitored contusion model of spinal cord injury in the rat. J. Neurotrauma 9 (1992) 123-126
15. Hsu J.Y., McKeon R., Goussev S., Werb Z., Lee J.U., Trivedi A., and Noble-Haeusslein L.J. Matrix metalloproteinase-2 facilitates wound healing events that promote functional recovery after spinal cord injury. J. Neurosci. 26 (2006) 9841-9850
16. Kim G.W., Gasche Y., Grzeschik S., Copin J.C., Maier C.M., and Chan P.H. Neurodegeneration in striatum induced by the mitochondrial toxin 3-nitropropionic acid: role of matrix metalloproteinase-9 in early blood-brain barrier disruption?. J. Neurosci. 23 (2003) 8733-8742
17. Kuh S.U., Cho Y.E., Yoon D.H., Kim K.N., and Ha Y. Functional recovery after human umbilical cord blood cells transplantation with brain-derived neutrophic factor into the spinal cord injured rat. Acta Neurochir. (Wien) 147 (2005) 985-992
18. Levine J.M. Increased expression of the NG2 chondroitin-sulfate proteoglycan after brain injury. J. Neurosci. 14 (1994) 4716-4730
19. McKeon R.J., Schreiber R.C., Rudge J.S., and Silver J. Reduction of neurite outgrowth in a model of glial scarring following CNS injury is correlated with the expression of inhibitory molecules on reactive astrocytes. J. Neurosci. 11 (1991) 3398-3411
20. McKeon R.J., Jurynec M.J., and Buck C.R. The chondroitin sulfate proteoglycans neurocan and phosphacan are expressed by reactive astrocytes in the chronic CNS glial scar. J. Neurosci. 19 (1999) 10778-10788
21. Muir E.M., Adcock K.H., Morgenstern D.A., Clayton R., von Stillfried N., Rhodes K., Ellis C., Fawcett J.W., and Rogers J.H. Matrix metalloproteases and their inhibitors are produced by overlapping populations of activated astrocytes. Brain Res. Mol. Brain Res. 100 (2002) 103-117
22. Nguyen M., Arkell J., and Jackson C.J. Human endothelial gelatinases and angiogenesis. Int. J. Biochem. Cell Biol. 33 (2001) 960-970
23. Noble L.J., Donovan F., Igarashi T., Goussev S., and Werb Z. Matrix metalloproteinases limit functional recovery after spinal cord injury by modulation of early vascular events. J. Neurosci. 22 (2002) 7526-7535
24. Reier P.J. Gliosis following CNS injury: the anatomy of astrocytic scars and their influences on axonal elongation. In: Federoff S., and Vernadakis A. (Eds). Astrocytes (1986), Academic, Orlando, Florida 263-324
25. Rosenberg G.A. Matrix metalloproteinases in brain injury. J. Neurotrauma 12 (1995) 833-842
26. Rosenberg G.A. Matrix metalloproteinases in neuroinflammation. Glia 39 (2002) 279-291
27. Rosenberg G.A., Dencoff J.E., McGuire P.G., Liotta L.A., and Stetler-Stevenson W.G. Injury-induced 92-kilodalton gelatinase and urokinase expression in rat brain. Lab. Invest. 71 (1994) 417-422
28. Rosenberg G.A., Estrada E.Y., Dencoff J.E., and Stetler-Stevenson W.G. Tumor necrosis factor-alpha-induced gelatinase B causes delayed opening of the blood-brain barrier: an expanded therapeutic window. Brain Res. 703 (1995) 151-155
29. Rosenberg G.A., Dencoff J.E., Correa Jr. N., Reiners M., and Ford C.C. Effect of steroids on CSF matrix metalloproteinases in multiple sclerosis: relation to blood-brain barrier injury. Neurology 46 (1996) 1626-1632
30. Rosenberg G.A., Estrada E.Y., and Dencoff J.E. Matrix metalloproteinases and TIMPs are associated with blood-brain barrier opening after reperfusion in rat brain. Stroke 29 (1998) 2189-2195
31. Saporta S., Kim J.J., Willing A.E., Fu E.S., Davis C.D., and Sanberg P.R. Human umbilical cord blood stem cells infusion in spinal cord injury: engraftment and beneficial influence on behavior. J. Hematother. Stem Cell Res. 12 (2003) 271-278
32. Stamenkovic I. Matrix metalloproteinases in tumor invasion and metastasis. Semin. Cancer Biol. 10 (2000) 415-433
33. Sternlicht M.D., and Werb Z. Extracellular matrix proteinases. In: Kreis T., and Vale R. (Eds). Guidebook to the Extracellular Matrix, Anchor and Adhesion Proteins (1999), Oxford University Press, New York 503-603
34. Trivedi A., Hsu J.Y., Lin Y., Goussev S., Gan J., Topp K.S., and Noble-Haeusslein L.J. The effects of acute and extended inhibition of matrix metalloproteinases on demyelination and functional recovery after spinal cord injury. Int. J. Neuroprotect. Neuroregen. 2 (2005) 30-38
35. Wells J.E., Rice T.K., Nuttall R.K., Edwards D.R., Zekki H., Rivest S., and Yong V.W. An adverse role for matrix metalloproteinase 12 after spinal cord injury in mice. J. Neurosci. 23 (2003) 10107-10115
36. Yong V.W. Metalloproteinases: mediators of pathology and regeneration in the CNS. Nat. Rev., Neurosci. 6 (2005) 931-944
37. Yong V.W., Power C., Forsyth P., and Edwards D.R. Metalloproteinases in biology and pathology of the nervous system. Nat. Rev., Neurosci. 2 (2001) 502-511
38. Zhao B.Q., Wang S., Kim H.Y., Storrie H., Rosen B.R., Mooney D.J., Wang X., and Lo E.H. Role of matrix metalloproteinases in delayed cortical responses after stroke. Nat. Med. 12 (2006) 441-445
39. Zheng Y., Watanabe N., Nagamura-Inoue T., Igura K., Nagayama H., Tojo A., Tanosaki R., Takaue Y., Okamoto S., and Takahashi T.A. Ex vivo manipulation of umbilical cord blood-derived hematopoietic stem/progenitor cells with recombinant human stem cell factor can up-regulate levels of homing-essential molecules to increase their transmigratory potential. Exp. Hematol. 31 (2003) 1237-1246
40. Zuo J., Ferguson T.A., Hernandez Y.J., Stetler-Stevenson W.G., and Muir D. Neuronal matrix metalloproteinase-2 degrades and inactivates a neurite-inhibiting chondroitin sulfate proteoglycan. J. Neurosci. 18 (1998) 5203-5211